Cosmo NV (CMOPF)
72.37
+1.90
(+2.70%)
USD |
OTCM |
Sep 04, 16:00
Cosmo Research and Development Expense (Quarterly)
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Avadel Pharmaceuticals Plc | 27.01M |
| Jazz Pharmaceuticals Plc | 207.50M |
| Perrigo Co. Plc | 23.70M |
| GH Research Plc | 12.40M |
| Alkermes Plc | 111.12M |